while everyone is focused on the Vaxinia trial update I am expecting if not more excited to see further evidence Her-vaxx is a commercially near term reality.
I believe the current share price capping is in preparation of a Her-vaxx sale or licensing deal. That’s our short term rerate
IMO
while everyone is focused on the Vaxinia trial update I am...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.003(5.88%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.5¢ | 5.1¢ | $775.6K | 14.60M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 3406278 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 2541120 | 18 |
View Market Depth
| Last trade - 12.01pm 10/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |